Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Taliglucerase alfa (Elelyso)

[1] Taliglucerase alfa (Elelyso (TN)) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

2

Elelyso 60 units/kg

[1] Taliglucerase alfa (Elelyso)

[1] Taliglucerase alfa (Elelyso (TN)) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

3

TALIGLUCERASE ALFA
(Elelyso (TN))

[1] Taliglucerase alfa (Elelyso)

[1] Taliglucerase alfa (Elelyso (TN)) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

4

Taliglucerase alfa - Recombinant human glucocerebrosidase
(Elelyso (TN))

[1] Taliglucerase alfa (Elelyso)

[1] Taliglucerase alfa (Elelyso (TN)) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬